The Role of Lazertinib in Patients with EGFR -Variant Non-Small Cell Lung Cancer

Haiying Cheng

doi:10.1001/jamaoncol.2024.2607

The Role of Lazertinib in Patients with EGFR -Variant Non-Small Cell Lung Cancer

Haiying Cheng

Oncology

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1352-1353
Number of pages	2
Journal	JAMA Oncology
Volume	10
Issue number	10
DOIs	https://doi.org/10.1001/jamaoncol.2024.2607
State	Published - Oct 17 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1001/jamaoncol.2024.2607

Cite this

@article{47f9dff2a2f640c883ead76de0931cbf,

title = "The Role of Lazertinib in Patients with EGFR -Variant Non-Small Cell Lung Cancer",

author = "Haiying Cheng",

year = "2024",

month = oct,

day = "17",

doi = "10.1001/jamaoncol.2024.2607",

language = "English (US)",

volume = "10",

pages = "1352--1353",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "10",

}

TY - JOUR

T1 - The Role of Lazertinib in Patients with EGFR -Variant Non-Small Cell Lung Cancer

AU - Cheng, Haiying

PY - 2024/10/17

Y1 - 2024/10/17

UR - https://www.scopus.com/pages/publications/85201774997

UR - https://www.scopus.com/pages/publications/85201774997#tab=citedBy

U2 - 10.1001/jamaoncol.2024.2607

DO - 10.1001/jamaoncol.2024.2607

M3 - Comment/debate

C2 - 39145952

AN - SCOPUS:85201774997

SN - 2374-2437

VL - 10

SP - 1352

EP - 1353

JO - JAMA Oncology

JF - JAMA Oncology

IS - 10

ER -

The Role of Lazertinib in Patients with EGFR -Variant Non-Small Cell Lung Cancer

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this